Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ivan Inigo
Targeting the TGFβ Pathway With Galunisertib, a TGFβRI SMI, Promotes Anti-Tumor Immunity Leading to Durable, Complete Responses, as Monotherapy and in Combination With Checkpoint Inhibition
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Related publications
Anti-Nkg2a mAb Is a Checkpoint Inhibitor That Promotes Anti-Tumor Immunity by Unleashing Both T and NK Cells
Cell
Biochemistry
Genetics
Molecular Biology
Combining Anti-Ctla4 With RG7787, an Immunotoxin Targeting Mesothelin, Promotes Tumor Eradication
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Targeting NKT Cells and PD-L1 Pathway Results in Augmented Anti-Tumor Responses in a Melanoma Model
Cancer Immunology, Immunotherapy
Cancer Research
Medicine
Oncology
Allergy
Immunology
Chemoradiation Combined With Phosphatidylserine-Targeting Antibody Enhances Systemic Anti-Tumor Immune Responses
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Schweinfurthin Natural Products Induce Regression of Murine Melanoma and Pair With Anti-Pd-1 Therapy to Facilitate Durable Tumor Immunity
OncoImmunology
Oncology
Allergy
Immunology
Targeting PIM Kinase With PD1 Inhibition Improves Immunotherapeutic Anti-Tumor T Cell Response
Clinical Cancer Research
Cancer Research
Oncology
Copanlisib in Combination With Anti-Pd-1 Induces Regression in Animal Tumor Models Insensitive or Resistant to the Monotherapies of Pi3k and Checkpoint Inhibitors
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Inhibition of Ataxia-Telangiectasia Mutated and RAD3-related (ATR) Overcomes Oxaliplatin Resistance and Promotes Anti-Tumor Immunity in Colorectal Cancer.
Cancer Research
Cancer Research
Oncology
TGFβ Blockade Enhances Radiotherapy Abscopal Efficacy Effects in Combination With Anti-Pd1 and Anti-Cd137 Immunostimulatory Monoclonal Antibodies
Molecular Cancer Therapeutics
Cancer Research
Oncology